# A survey of current trends in computational drug repositioning
### Jiao Li, Si Zheng, Bin Chen, Atul j.Butte, S. Joshua Swamidass and Zhiyoung Lu
<hr/>

#### Network analysis
1. Intro
	> Network-based analysis is used strategy for computational drug repositioning.
	> Previous studies have suggested that drug-target network, drug-drug network, drug-disease network, protein interaction network, transcriptional networks and signaling networks are useful in the identification of therapeutic targets of characteristics of drug targets, thus providing new opportunities for drug discovery or repositioning.

2. Li et al
	> 비슷한 약들의 관계를 통해 이미 존재하는 약의 새로운 징후를 찾는 the bipartite drug-target network method를 개발함.
	> 이 the bipartite network model 에선, Drug pair similarity는 drug chemical structure similarity와 common drug targets 그리고 그들의 interaction을 포함하고있다.
3. Wu et al

4. Jin et al



#### Text mining and semantic inference
1. Intro
2. Andronis et al
	> literature mining approaches와 sources for drug repurposing을 사용했는데,
	> 질병 A가 영양소 B의 부족으로 인해 발생 되는게 발견되고,
	> 또 다른 연구에서 약 C가 영양소 B의 개시자로 사용되는것이 발견되면,
	> 약 C는 질병 A를 위해 리포지셔닝 될 수 도 있다는 것을 발견했다.
3. Zhu et al
4. Chen et al

#### Validation for computational drug repositioning
1. Intro
2. Zerbini et al
3. Kang et al
4. Vegner et al
5. Khatri el al
6. Xu et al


#### Current and future target areas: cancers, infectous and orphan diseases and personalized medicine
1. Intro
2. Li et al

#### Discussion
1. Intro
2. Challenges
	1. The transformation of theoretical omputational models into practical use is far from straightforward, due to some inevitable factors like missing data, data bias and technical limitations of computational methods.
	2. The lack of structured gold standard for drug repoisitioning made it hard to compare and evaluate the performance of computatinal methods.
	3. Although computational drug repoisitioning may merely shorten the process of drug discovery in preclinical and Phase Ⅰ  trials, challenges may still exist after Phase Ⅱ trials for the repositioned drugs

#### Conclusions


#### Keypoint
1. Various type of big data are publicly available for computational drug repoisitioning
2. Integrative repoisitioning strategies for heterogeneous data can help find new uses of old drugs.
3. Computational drug repoisitioning shows promises in accelerating drug discoveries for cancer and infectious and orphan diseases.


